[{"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0194-2019", "product_description": "Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1352-05", "product_quantity": "9 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04262018:09 Discard by: 10/22/2018; 07022018:48 Discard by: 12/29/2018"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "80997", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1209-2018", "product_description": "Minivelle (estradiol transdermal system) Patches, Delivers 0.025 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6625-8", "product_quantity": "26217 boxes of 8 patches", "reason_for_recall": "Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.", "recall_initiation_date": "20180907", "center_classification_date": "20180925", "termination_date": "20200909", "report_date": "20181003", "code_info": "Lots: 82199 Exp. 12/2018; 83025 Exp. 05/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0160-2019", "product_description": "HCG Lyopholized 1200 IU Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-1743-12", "product_quantity": "881 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04092018:58 Discard by: 10/6/2018; 06072018:03 Discard by: 12/4/2018; 05292018:86 Discard by: 11/25/2018; 07192018:64 Discard by: 1/15/2019; 08302018:30 Discard by: 2/26/2019"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA078020"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6321", "0378-6322", "0378-6323", "0378-6324", "0378-6325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["16044239-373d-4b04-9a4d-fd4232a93b6c"], "spl_set_id": ["3ba1f9f9-0037-4522-8605-e27dc8552b5b"], "package_ndc": ["0378-6321-77", "0378-6321-05", "0378-6322-77", "0378-6322-05", "0378-6323-77", "0378-6323-05", "0378-6324-77", "0378-6324-05", "0378-6325-77", "0378-6325-05"], "is_original_packager": [true], "upc": ["0303786323777"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0332-2019", "product_description": "Valsartan and Hydrochlorothiazide Tablets, USP 320/25 mg, (a) 90-count bottle (NDC 0378-6325-77), (b) 500-count bottles (NDC 0378-6325-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "32,284 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot numbers:    3084860  3084861    3084862    3093804    3084862    3084863"}, {"country": "United States", "city": "Oshkosh", "address_1": "2155 S Oakwood Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "53 bottles", "code_info": "Lot K111717A", "center_classification_date": "20181119", "distribution_pattern": "Nationwide USA", "state": "WI", "product_description": "Native Remedies VaricoGo Oral Spray, 2 fl oz (59 mL) per bottle, Distributed by:  Silver Star Brands, Oshkosh, WI 54906.  NDC 68703-105-59", "report_date": "20181114", "classification": "Class I", "openfda": {}, "recalling_firm": "Silver Star Brands", "recall_number": "D-0253-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "81228", "termination_date": "20190825", "more_code_info": "", "recall_initiation_date": "20181003", "postal_code": "54904-6359", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0200-2019", "product_description": "Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/20 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1366-02", "product_quantity": "815 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03292018:70 Discard by: 9/25/2018; 05302018:94 Discard by: 11/26/2018; 06072018:67 Discard by: 12/4/2018; 06122018:72 Discard by: 12/9/2018; 07252018:72 Discard by: 1/21/2019"}, {"status": "Terminated", "city": "West Jordan", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81556", "recalling_firm": "CAO Group, Inc.", "address_1": "4628 W Skyhawk Dr", "address_2": "N/A", "postal_code": "84084-4501", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0291-2019", "product_description": "SHEER DesenZ Desensitizing Treatment, Rx Only, Potassium Nitrate 12mg per film. CAO GROUP, INC, 4628 West Skyhawk Drive West Jordan, UT 84084. UPC: 8 72320 00072 1 NDC 1406000304", "product_quantity": "71 cartons", "reason_for_recall": "cGMP violations noted during the firm's most recent inspection.", "recall_initiation_date": "20181116", "center_classification_date": "20181211", "termination_date": "20200227", "report_date": "20181219", "code_info": "Lot # 170626, EXP 6/26/2019;  and 180131, EXP 01/31/2020"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0111-2019", "product_description": "AllergEase, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0003-1", "product_quantity": "4,153 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0191-2019", "product_description": "Tri-Mix Papaverine/Phentolamine/Alprostadil 150 mg/5 mg/50 mcg a) Injectable NDC 69699-1332-05 b) (LYO) Powder NDC 69699-1332-05, Pharm D Solutions, Houston, Texas", "product_quantity": "609 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: a) 09062018:87 Discard by: 1/14/2019 b) 04042018:44 Discard by: 10/29/2018; 09022018:04 Discard by: 3/1/2019; 05212018:44 Discard by: 11/17/2018; 06122018:83 Discard by: 12/9/2018; 08132018:86 Discard by: 2/9/2019"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0053-2019", "product_description": "Thayers Natural Remedies, Saline Nasal Spray, Allergy & Sinus Relief, Slippery Elm, 1.5 FL OZ (44 mL) bottle, Distributed By: Product Quest Manufacturing, LLC, 330 Carswell Ave., Daytona Beach, FL 32117, UPC 7 27510 00660 4.", "product_quantity": "22,392 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Grand Rapids", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["NEORELIEF FOR MUSCLE CRAMPLING AND RESTLESSNESS"], "generic_name": ["TOPICAL GEL FOR MUSCLE CRAMPING AND RESTLESSNESS"], "manufacturer_name": ["BioLyte Laboratories, LLC"], "product_ndc": ["58368-002"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ARNICA MONTANA", "ARTEMISIA CINA PRE-FLOWERING TOP", "ATROPA BELLADONNA ROOT", "BLACK COHOSH", "CAUSTICUM", "FRANGULA CALIFORNICA BARK", "HYPERICUM PERFORATUM", "JATROPHA CURCAS SEED", "LYCOPODIUM CLAVATUM SPORE", "POTASSIUM BROMIDE", "POTASSIUM CARBONATE", "PSEUDOGNAPHALIUM OBTUSIFOLIUM", "RUTA GRAVEOLENS FLOWERING TOP", "SCUTELLARIA LATERIFLORA", "STRYCHNOS IGNATII SEED", "TARAXACUM OFFICINALE", "VALERIAN", "VERATRUM ALBUM ROOT"], "spl_id": ["24891531-c4df-73dd-e063-6394a90a2d6b"], "spl_set_id": ["46da3f0e-9dd1-6495-e054-00144ff8d46c"], "package_ndc": ["58368-002-02"], "is_original_packager": [true], "unii": ["O80TY208ZW", "28M1820ACT", "6MW97Q6E8M", "K73E24S6X9", "DD5FO1WKFU", "1LZ13MQR0S", "XK4IUX8MNB", "J0F5GM8LA8", "C88X29Y479", "OSD78555ZM", "BQN1B9B9HA", "36XQ854NWW", "N94C2U587S", "7BP4DH5PDC", "1NM3M2487K", "39981FM375", "JWF5YAW3QW", "QNS6W5US1Z"]}, "product_type": "Drugs", "event_id": "81011", "recalling_firm": "BioLyte Laboratories, LLC", "address_1": "310 Northern Dr. Nw", "address_2": "", "postal_code": "49534", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0002-2019", "product_description": "NeoRelief for Muscle Cramping & Restlessness Homeopathic Topical Gel, packaged in a) 4 ml sample packs and b) Net Wt. 2.0 oz (56.7g) bottles, BioLyte Laboratories - Grand Rapids, MI 49534, NDC 58368-002-02", "product_quantity": "a) 500 sample packs; b) 672 bottles", "reason_for_recall": "CGMP Deviations: finished product produced with active ingredients recalled by the manufacturer, King Bio Inc., due to water contamination issues that could potentially affect the quality of this product.", "recall_initiation_date": "20180831", "center_classification_date": "20181001", "termination_date": "20200831", "report_date": "20181010", "code_info": "Lot #: a) 1146, Exp 3/29/20; b) 1138, 1139, Exp 1/31/20; and 1160, Exp 10/10/19", "more_code_info": ""}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0113-2019", "product_description": "DigestivEase, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879.NDC 61096-0005-1", "product_quantity": "1,465 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Monmouth Junction", "address_1": "2033 US Highway 130", "reason_for_recall": "Superpotent Drug: recalled lots may have higher concentration of ibuprofen.", "address_2": "", "product_quantity": "164,304 bottles", "code_info": "Lot #: 00717009A, Exp 02/19; 00717015A, Exp 04/19; 00717024A, Exp 08/19", "center_classification_date": "20181217", "distribution_pattern": "One distributor in PA who further distributed Nationwide in the USA.", "state": "NJ", "product_description": "infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23,  UPC 0 78742 02016 7.", "report_date": "20181226", "classification": "Class II", "openfda": {}, "recalling_firm": "Tris Pharma Inc.", "recall_number": "D-0335-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81354", "termination_date": "20210401", "more_code_info": "", "recall_initiation_date": "20181126", "postal_code": "08852-3003", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA078020"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6321", "0378-6322", "0378-6323", "0378-6324", "0378-6325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["16044239-373d-4b04-9a4d-fd4232a93b6c"], "spl_set_id": ["3ba1f9f9-0037-4522-8605-e27dc8552b5b"], "package_ndc": ["0378-6321-77", "0378-6321-05", "0378-6322-77", "0378-6322-05", "0378-6323-77", "0378-6323-05", "0378-6324-77", "0378-6324-05", "0378-6325-77", "0378-6325-05"], "is_original_packager": [true], "upc": ["0303786323777"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0330-2019", "product_description": "Valsartan and Hydrochlorothiazide Tablets, USP 160/25 mg, (a) 90-count bottle (NDC 0378-6323-77), (b) 500-count bottles (NDC 0378-6323-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "22,813 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot numbers:  3084887    3093802    3084887    3084888    3093802"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0126-2019", "product_description": "Diet Power, Homeopathic Oral Spray 1.38 fl. oz. (41 mL). Manufactured by Sprayology Gaithersburg, MD 20879. NDC 61096-0004-1", "product_quantity": "3634 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Grand Island", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA088912"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807632", "1807636", "1807637", "1807638"], "spl_id": ["75c567e3-582b-4fff-9a72-f326f1d13c8f"], "spl_set_id": ["f62481fd-fcdb-4be6-ac13-29c590e925c3"], "package_ndc": ["63323-186-04", "63323-186-02", "63323-186-01", "63323-186-10", "63323-186-03", "63323-186-20"], "is_original_packager": [true], "upc": ["0363323186036"], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "81570", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3159 Staley Rd", "address_2": "N/A", "postal_code": "14072-2028", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Puerto RIco", "recall_number": "D-0299-2019", "product_description": "SODIUM CHLORIDE INJECTION, USP, 0.9%, 20 mL Single Dose Vial, packaged in a 25-unit tray, Rx Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173. NDC 63323-186-20,  Product code 918620", "product_quantity": "1,312,350 20 mL vials", "reason_for_recall": "Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex.  The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex.  The above listed product codes and batches being recalled have stoppers containing natural rubber latex.", "recall_initiation_date": "20181115", "center_classification_date": "20181214", "termination_date": "20230501", "report_date": "20181212", "code_info": "Lot#          EXP date:   6013062 11/2018  6014162 05/2019  6014163 05/2019  6014164 05/2019  6014377 06/2019  6014378 06/2019  6014379 06/2019  6016005 02/2020  6016071 02/2020  6016072 02/2020  6016073 02/2020  6017383 07/2020  6017384 07/2020  6017422 07/2020  6017423 07/2020  6017424 07/2020"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA208061"], "brand_name": ["TESTOSTERONE"], "generic_name": ["TESTOSTERONE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-943"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TESTOSTERONE"], "rxcui": ["1599949"], "spl_id": ["8882a012-97f5-40c7-a64c-2898d70a1554"], "spl_set_id": ["29c8846f-121c-4958-9e03-3bd271c21558"], "package_ndc": ["68180-943-11"], "is_original_packager": [true], "nui": ["N0000175824", "N0000000146", "M0001109"], "pharm_class_epc": ["Androgen [EPC]"], "pharm_class_moa": ["Androgen Receptor Agonists [MoA]"], "pharm_class_cs": ["Androstanes [CS]"], "unii": ["3XMK78S47O"]}, "product_type": "Drugs", "event_id": "81213", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0087-2019", "product_description": "Testosterone Topical Solution, 30mg/1.5mL, 110mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-943-11", "product_quantity": "6,752 bottles", "reason_for_recall": "Defective Container: Repetitive complaints received indicating pump not working.", "recall_initiation_date": "20181009", "center_classification_date": "20181023", "termination_date": "20191216", "report_date": "20181031", "code_info": "Lot #: K700085, K700087, Exp. November 2019"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81041", "recalling_firm": "GLAXOSMITHKLINE NEBRASKA", "address_1": "10401 Hwy 6", "address_2": "", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0088-2019", "product_description": "Prevacid 24HR (Lansoprazole) delayed-release capsules, 15 mg, 14 capsules per bottle in a carton containing 1 bottle (NDC: 0067-6286-14), 2 bottles (NDC: 0067-6286-28) or 3 bottles (NDC: 0067-6286-42), Over-the-counter, Distributed By: GSK Consumer Healthcare, Warren, NJ 07059.", "product_quantity": "5,548,673 bottles", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20180926", "center_classification_date": "20181023", "termination_date": "20201106", "report_date": "20181017", "code_info": "1-bottle cartons lot #:  GE2743, GE4570, GG0536, Exp 9/30/2018; GE3445, GG4810, Exp 11/30/2018; A38M, Exp 12/31/2018; K63J, Exp 4/30/2018; H24T, Exp 5/31/2018; RS4U, M721601MA, Exp 7/31/2018; 379H, Exp 8/31/2018; A93E, AE2S, Exp 10/31/2018; GB7D, GS5B, M801001MA, M807901MA, M807902MA, exp 11/30/2019; D88E, Exp 11/30/2020    2-bottle cartons lot#:  GJ0440, Exp 1/31/2019; LE6J, Exp 7/31/2018; A93E, Exp 10/31/2018    3-bottle cartons lot#: 17D19N, Exp 8/31/2018; 1GE2743, GE4570, GG0536, Exp 9/30/2018; GA8391, Exp 10/31/2018; GE3445, GA6310, Exp 11/30/2018; GG1094, GH1913, GH8818, M703002EH, M703003EH, M703004EH, M703006EH, M703007EH, M703008EH, M713101EH, M707401MB, M707402MB, M707403MB, M707404MB, M707405MB, M707406MB, M721201MB, M717001MA, M717002MA, Exp 1/31/2018; AF5C, AK2T, AV5T, M713102EH, M713104EH, M716001EH, M716002EH, M716003EH, M716004EH, M716005EH, M721202MB, M721203MB, M721204MB, M717003MA, M717004MA, M717005MA, M717006MA, Exp 4/30/2019; FL8P, FM4K, M720505EH, M720507EH, M720508EH, M720509EH, M721205MB, M721206MB, M721207MB, Exp 5/31/2019; P77N, P77P, PN3Y, R72E, Exp 8/31/2019; 728J, 728K, 728L, 8E6T, A93E, Exp 10/31/2019; H43X, HT4P, M85L, Exp 11/30/2019; T73J, UT9X, UV7Y, Exp 2/29/2019; BR4Y, FN2N, Exp 11/30/2020; MC2P, MJ9F, RC2T, Exp 1/31/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0181-2019", "product_description": "Sermorelin/GHRP-2 18 mg/6 mg powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1748-10", "product_quantity": "124 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04232018:89 Discard by: 10/15/2018"}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81603", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "WA only", "recall_number": "D-0285-2019", "product_description": "Germ Bloc Health Hand Sanitizer Foam (benzalkonium chloride 0.13%) 7.5fl.oz./222mL refill bags, AvKARE, Inc. Pulaski, TN 38478 www.avkare.com, NDC 5026835427, UPC 3 50268 35408", "product_quantity": "1602 bags", "reason_for_recall": "Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas aeruginosa in product", "recall_initiation_date": "20181120", "center_classification_date": "20181128", "termination_date": "20200507", "report_date": "20181205", "code_info": "Lot #: 13417 Exp. 05/2020"}, {"status": "Terminated", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81061", "recalling_firm": "Humco Holding Group, Inc", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0023-2019", "product_description": "Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 100 grams NDC 0395-8077-62 Packaged by: Humco Texarkana, TX 75501 USA", "product_quantity": "Unknown.", "reason_for_recall": "CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.", "recall_initiation_date": "20180828", "center_classification_date": "20181012", "termination_date": "20200507", "report_date": "20181024", "code_info": "Lots: A24543 Exp. 02/2019; A25724 Exp. 01/2019; A25529 Exp. 04/2019; A25723 Exp. 04/2019; A27120 Exp. 05/2019; A27811 Exp. 06/2019; A28626 Exp. 06/2019; A29171 Exp. 06/2019; A29221 Exp. 06/2019"}, {"status": "Terminated", "city": "Erlanger", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81606", "recalling_firm": "LGM Pharma LLC", "address_1": "2758 Circleport Dr", "address_2": "N/A", "postal_code": "41018-1079", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0296-2019", "product_description": "Thyroid Powder, USP, 25kg/drum, Rx Only, Sichuan Friendly Pharmaceutical Co., LTD. NDC: 070870-1701-1", "product_quantity": "1,307 kg", "reason_for_recall": "CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.", "recall_initiation_date": "20180824", "center_classification_date": "20181212", "termination_date": "20230911", "report_date": "20181219", "code_info": "Lots: 161101, EXP 11/2/2016; 161201, EXP Nov 2018; 170301, EXP Feb 2019; 170501, Exp Apr 2019; 170701, Exp Jun 2019"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0142-2019", "product_description": "Bi-Mix Injection, (Alprostadil 40 mcg/Lidocaine 2 mg/mL) Pharm D Solutions, Houston, Texas --- NDC 69699-1305-03", "product_quantity": "148 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 04112018:37 Discard by: 10/1/2018; 06202018:70 Discard by: 12/16/2018; 08082018:95 Discard by: 2/4/2019"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C235 BUD: 11/10/2018; C241 BUD: 11/17/2018; C251 BUD: 12/8/2018; C265 BUD: 12/28/2018; D008 BUD: 1/9/2019; D018 BUD: 1/19/2019; D022 BUD: 1/25/2019; D032 BUD: 2/7/2019; D037 BUD: 2/13/2019; D057 BUD: 3/8/2019; D061 BUD: 3/14/2019; D069 BUD: 3/23/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 25 mg pellet, 1 count (NDC: 69761-125-01) and 30 count vials (NDC: 69761-125-30), Rx Only Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0234-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Arutla", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81442", "recalling_firm": "Aurobindo Pharma Limited (Unit I)", "address_1": "385 386 Bulk Active Plant", "address_2": "Unit I; Survey 379", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one customer in NY.", "recall_number": "D-0127-2019", "product_description": "Irbesartan Bulk Active Pharmaceutical Ingredient.", "product_quantity": "1724.8 kgs.", "reason_for_recall": "CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.", "recall_initiation_date": "20181024", "center_classification_date": "20181031", "termination_date": "20200327", "report_date": "20181107", "code_info": "Manufacturing batch numbers:  1601100782, dispatch batch number 1601101589, exp. date 12/01/2018  1601100783, dispatch batch number 1601101590, exp. date 12/01/2018  1701111861, dispatch batch number 1701113404, exp. date 09/01/2020  1701112170, dispatch batch number 1701113405, exp. date 09/01/2020  1701112501, dispatch batch number 1701113406, exp. date 09/01/2020  1701112056, dispatch batch number 1701113407, exp. date 09/01/2020  1701112558, dispatch batch number 1701114283, exp. date 10/01/2020  1701112559, dispatch batch number 1701114285, exp. date 10/01/2020  1701112589, dispatch batch number 1701114286, exp. date 10/01/2020  1701113300, dispatch batch number 1701114289, exp. date 10/01/2020  1701113301, dispatch batch number 1701114291, exp. date 10/01/2020  1701113302, dispatch batch number 1701114708, exp. date 10/01/2020  1701113312, dispatch batch number 1701114709, exp. date 10/01/2020  1701115460, dispatch batch number 1701117039, exp. date 11/01/2020  1701115974, dispatch batch number 1701117040, exp. date 11/01/2020  1701115460, dispatch batch number 1701117041, exp. date 11/01/2020  1701115738, dispatch batch number 1701117042, exp. date 11/01/2020  1701115739, dispatch batch number 1701117043, exp. date 11/01/2020  1701115740, dispatch batch number 1701117044, exp. date 11/01/2020  1701115741, dispatch batch number 1701117045, exp. date 11/01/2020  1701115742, dispatch batch number 1701117046, exp. date 11/01/2020"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0048-2019", "product_description": "Premier Value, Saline Nasal Spray, Sodium Chloride 0.65%, packaged as a) 3 FL OZ (88 mL) bottle NDC 68016-388-00 UPC 8 40986 01483 3; b) 1.5 FL OZ (44 mL) bottle NDC 68016-466-00 UPC 8 40986 01482 6, Distributed By Chain Drug Consortium, 3301 NW Boca Raton Blvd, Suite 101, Boca Raton, FL 33431.", "product_quantity": "102,348 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0186-2019", "product_description": "Slenderella Compound Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1617-30", "product_quantity": "5000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04202018:59 Discard by: 10/17/2018; 08282018:46 Discard by: 2/1/2019"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81083", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0007-2019", "product_description": "Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 units/gm & 1 mg/gm, packaged in a) 15 g tube (NDC 43598-431-44), b) 30 g tube (NDC 43598-431-30), c) 60 g tube (NDC 43598-431-60), Rx only, Distributor: Dr. Reddy's Laboratories, Inc. 107 College Road East, Princeton, NJ - 08540 Rx Only Made in India", "product_quantity": "35020 tubes", "reason_for_recall": "Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.", "recall_initiation_date": "20180921", "center_classification_date": "20181004", "termination_date": "20230217", "report_date": "20181010", "code_info": "Lot #: a) D06017, D06018, Exp 9/18; D06028 Exp 10/18; b) D06014, D06015, D06016, Exp 9/18; D06024, D06025, D06026, D06027, Exp 10/2018; c) D06011, D06012, D06013, Exp 9/18; D06020, D06021, D06022, D06023, Exp 10/2018", "more_code_info": ""}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81646", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide including Puerto Rico.", "recall_number": "D-0303-2019", "product_description": "Amlodipine and Valsartan Tablets 5 mg/160 mg, (a) 30-count bottles (NDC 0093-7690-56) & 90-count bottles (NDC 0093-7690-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.", "product_quantity": "120,394 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181127", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "NDC 0093-7690-56 & NDC 0093-7690-98  Lot # 23X017, 23X018, 23X019, 23X020, 23X022, 23X023, 23X024"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0049-2019", "product_description": "QC Quality Choice, Saline Nasal Gel with Soothing Aloe, 0.5 OZ (14.1 g) tube, Distributed by C.D.M.A., Inc., 43157 W. Nine Mile, Novi, MI 48376-0995, UPC 6 35515 99202 3.", "product_quantity": "4,200 tubes", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C247 BUD: 11/30/2018; C249 BUD: 12/5/2018; C266 BUD: 12/29/2018; D012 BUD: 1/12/2019; D029 BUD: 2/2/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 50mg pellet, 1 count (NDC 69761-150-01), 6 count (NDC 69761-150-06), 12 count (NDC 69761-150-12), and 30 count (NDC 69761-150-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0236-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206422"], "brand_name": ["FLUOCINOLONE ACETONIDE"], "generic_name": ["FLUOCINOLONE ACETONIDE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-069"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191310"], "spl_id": ["15764733-88e0-40bf-ac92-ff4e3e35b15d"], "spl_set_id": ["460f5a55-6437-4651-bc08-8063ca579c8d"], "package_ndc": ["43386-069-60"], "is_original_packager": [true], "upc": ["0343386069606"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"]}, "product_type": "Drugs", "event_id": "81168", "recalling_firm": "LUPIN SOMERSET", "address_1": "400 Campus Dr", "address_2": "N/A", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0092-2019", "product_description": "Fluocinolone Acetonide Topical Solution, USP 0.01%, 60ml Bottle, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, MD 21202 Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC  43386-069-60", "product_quantity": "2712 60-ml bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis", "recall_initiation_date": "20181005", "center_classification_date": "20181024", "termination_date": "20221108", "report_date": "20181031", "code_info": "Lot# M16666, EXP 12/2018"}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81646", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide including Puerto Rico.", "recall_number": "D-0305-2019", "product_description": "Amlodipine and Valsartan Tablets 5 mg/320 mg, (a) 30-count bottles (NDC 0093-7692-56) & 90-count bottles (NDC 0093-7692-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.", "product_quantity": "75,883 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181127", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "NDC 0093-7692-56 & NDC 0093-7692-98  Lot # 25X028, 25X029, 25X030, 25X031, 25X032, 25X035, 25X037"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81413", "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "address_1": "24416 N 19th Ave", "address_2": "N/A", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. nationwide.", "recall_number": "D-0134-2019", "product_description": "Phenylephrine 25 mg added to NS 250 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38", "product_quantity": "300 bags", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20181019", "center_classification_date": "20181101", "termination_date": "20210506", "report_date": "20181107", "code_info": "Lot# 138-20182308@88, Exp 11/06/2018"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80964", "recalling_firm": "Takeda Development Center Americas, Inc.", "address_1": "1 Takeda Pkwy", "address_2": "4034BB1", "postal_code": "60015-5713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AR, LA, MS, NC, NJ, OH, PA, SC and Puerto Rico", "recall_number": "D-0026-2019", "product_description": "Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals  America, Inc, Deerfield, IL 60015.  NDC: 64764-510-30", "product_quantity": "7,248 bottles", "reason_for_recall": "Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.", "recall_initiation_date": "20180910", "center_classification_date": "20181015", "termination_date": "20200413", "report_date": "20181017", "code_info": "Lot, expiry:  A26004, exp Apr 2020;  A26443 and A26444, exp Sep 2020", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0056-2019", "product_description": "Best Choice, 12 Hour Extra Moisturizing, Nasal Spray (Oxymetazoline Hydrochloride 0.05%), Nasal Decongestant, 1 FL OZ (30 mL) bottle, Proudly Distributed By: Valu Merchandisers, Co., 5000 Kansas Ave., Kansas City, KS 66106, UPC 0 70038 59328 7.", "product_quantity": "2,112 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Charlotte", "address_1": "2815 Coliseum Centre Dr Ste 600", "reason_for_recall": "CGMP Deviations: Product was released to market prior to microbiological testing.", "address_2": "", "product_quantity": "258 cases", "code_info": "Lot 9085", "center_classification_date": "20181106", "distribution_pattern": "NC", "state": "NC", "product_description": "Alcohol Free Foaming Hand Sanitizer (benzalkonium chloride), 0.13%, 1 L (33.8 fl. oz.) cartridge packaged in 8 cartridges per case, Safe-T-Fresh Inc., USA, 2530 Xenium Lane North, Minneapolis, MN 55441.", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "S.C. Johnson Professional", "recall_number": "D-0221-2019", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "81453", "termination_date": "20200908", "more_code_info": "", "recall_initiation_date": "20181026", "postal_code": "28217-0144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81004", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States", "recall_number": "D-0084-2019", "product_description": "Cortaid Intensive Therapy Cooling Spray (1% hydrocortisone), 2 FL OZ (59 mL) spray bottle, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875518028", "product_quantity": "18,408 bottles", "reason_for_recall": "CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.", "recall_initiation_date": "20180824", "center_classification_date": "20181022", "termination_date": "20200306", "report_date": "20181031", "code_info": "Lot #: 171205E, 171951E, Exp 5/19; 173365K, Exp 10/19"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA078020"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6321", "0378-6322", "0378-6323", "0378-6324", "0378-6325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["16044239-373d-4b04-9a4d-fd4232a93b6c"], "spl_set_id": ["3ba1f9f9-0037-4522-8605-e27dc8552b5b"], "package_ndc": ["0378-6321-77", "0378-6321-05", "0378-6322-77", "0378-6322-05", "0378-6323-77", "0378-6323-05", "0378-6324-77", "0378-6324-05", "0378-6325-77", "0378-6325-05"], "is_original_packager": [true], "upc": ["0303786323777"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0329-2019", "product_description": "Valsartan and Hydrochlorothiazide Tablets, USP 160/12.5 mg, (a) 90-count bottle (NDC 0378-6322-77), (b) 500-count bottles (NDC 0378-6322-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "50,595 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot numbers:  2008880    3084358    3084359    3093801    3084359    3084361    3093801"}, {"country": "United States", "city": "Titusville", "address_1": "1125 Trenton-Harbourton Rd.", "reason_for_recall": "Labeling: Incorrect Instructions; Instructions included  for use with the Veridate dispenser contained instructions for the Dialpak dispenser.", "address_2": "", "product_quantity": "1,777 cartons", "code_info": "Lot # 18BM114, Exp. 03/2020", "center_classification_date": "20181106", "distribution_pattern": "Nationwide in the USA", "state": "NJ", "product_description": "Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets, 1 mg/0.035 mg, 28-Day Regimen per pouch (NDC 50458-176-28), 6 Veridate Tablet Dispensers and 6 refills per carton (NDC 50458-176-06), Rx only, Manufactured by: Janssen Ortho, LLC, Manati, Puerto Rico 00674; Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, New Jersey 08560.", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Janssen Pharmaceuticals, Inc.", "recall_number": "D-0217-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81289", "termination_date": "20191030", "more_code_info": "", "recall_initiation_date": "20181023", "postal_code": "08560", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0183-2019", "product_description": "Sermorelin/GHRP-2 9 mg/9 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1715-10", "product_quantity": "250 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03202018:46 Discard by: 9/16/2018; 05012018:56 Discard by: 10/28/2018"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C253 BUD: 12/12/2018; D016 BUD: 1/18/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 15mg pellet, 1 count (NDC 69761-015-01), 6 count (NDC 69761-015-06), 12 count (NDC 69761-015-12), and 30 count (NDC 69761-015-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0227-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "81741", "recalling_firm": "Asclemed USA Inc. dba Enovachem", "address_1": "379 Van Ness Ave Ste 1403", "address_2": "", "postal_code": "90501-7211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Natonwide", "recall_number": "D-0353-2019", "product_description": "Dyural-40 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-0750-01", "product_quantity": "", "reason_for_recall": "Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex", "recall_initiation_date": "20181211", "center_classification_date": "20190109", "termination_date": "20230201", "report_date": "20181226", "code_info": "Lot #: 050518X5, 051618X1, Exp 1/31/19; 052318X4, Exp 5/1/19; 052318X5, 062818X1, 072518X3, 072718X1, 080318X2, 091818X2, Exp 5/31/19; 082318X4, 083118X1, 090518X4, 091818X4, Exp 6/30/19; 091818X3, Exp 7/31/19; 091818X5, 092418X1, 092818X4, 101018X3, 101018X5, Exp 8/31/19; 102418X5, Exp 9/30/19", "more_code_info": ""}, {"country": "United States", "city": "Hurst", "address_1": "122 Grapevine Hwy", "reason_for_recall": "Labeling Not Elsewhere Classified: Misbranding.", "address_2": "", "product_quantity": "180 capsules", "code_info": "Lots: 07232018@15 Exp. 1/19/2019; 08102018@10 Exp. 2/6/2019", "center_classification_date": "20181114", "distribution_pattern": "Distributed in California", "state": "TX", "product_description": "Tadalafil SR 12 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd's Prescription Shop 122 Grapevine Hwy. Hurst, TX 76054 817-282-9376  NDC 99999-9969-51", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "Right Value Drug Stores, Inc.", "recall_number": "D-0243-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81198", "termination_date": "20201013", "more_code_info": "", "recall_initiation_date": "20180925", "postal_code": "76054-2406", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0069-2019", "product_description": "Well at Walgreens, Scar Cream with SPF 30, (Avobenzone 3%, Octocrylene 10%, Oxybenzone 6%), 0.7 OZ (19.8 g) tube, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, UPC 3 11917 18281 0.", "product_quantity": "6,516 tubes", "reason_for_recall": "Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot: 163241K, Exp. October 2018"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0078-2019", "product_description": "Rexall, Extra Moisturizing No Drip Nasal Spray (Oxymetazoline Hydrochloride 0.05%) 1 FL OZ (30 mL) bottle, 48 pk. (12687901)", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0109-2019", "product_description": "MenoPower, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0014-1 and Tester NDC 61096-1014", "product_quantity": "2,301 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Lake Forest", "address_1": "150 N Field Dr Ste 350", "reason_for_recall": "Sub-potent", "address_2": "", "product_quantity": "295 100 mL in 150 mL Intravia bags", "code_info": "Lot: 183230004C Exp. 02/17/2019", "center_classification_date": "20181215", "distribution_pattern": "Nationwide in the USA.", "state": "IL", "product_description": "Fentanyl Citrate 2 mcg per mL (200 mcg per 100 mL) and Ropivacaine HCl 0.2% in Sodium Chloride 0.9%, Injection, 100 mL total volume in a 150 mL Intravia Bag, Rx Only,PharMEDium Services, LLC. 913 N. Davis Ave. Cleveland, MS 38732. NDC 61553-148-48", "report_date": "20181226", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmedium Services, LLC", "recall_number": "D-0334-2019", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "81730", "termination_date": "20201002", "more_code_info": "", "recall_initiation_date": "20181205", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0312-2019", "product_description": "Amlodipine and Valsartan Tablets, USP,10 mg/160 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-1722-93.", "product_quantity": "12,336 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3079500, exp. date 1/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0193-2019", "product_description": "Trimix BM3 Papaverine 30 mg/Phentolamine 1 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1354-03", "product_quantity": "20 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 07262018:58 Discard by: 1/21/2019"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA022458"], "brand_name": ["ELELYSO"], "generic_name": ["TALIGLUCERASE ALFA"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0069-0106"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TALIGLUCERASE ALFA"], "rxcui": ["1292879", "1292881"], "spl_id": ["9e5fbf74-2937-46bd-bfaa-b8aab9386998"], "spl_set_id": ["fa3cbd5d-677c-4b19-9032-d9182cb69a83"], "package_ndc": ["0069-0106-01"], "is_original_packager": [true], "nui": ["N0000175820", "M0009360"], "pharm_class_epc": ["Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"], "pharm_class_cs": ["Glucosylceramidase [CS]"], "unii": ["0R4NLX88O4"]}, "product_type": "Drugs", "event_id": "81050", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. nationwide.  The following countries received product from Lot S91616: Albania, South Africa, Israel, Afghanistan, Rwanda, Botswana, Zimbabwe and Iraq as part of the Compassionate Use Program.", "recall_number": "D-0005-2019", "product_description": "Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC  0069-0106-01", "product_quantity": "12,416 vials", "reason_for_recall": "Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection.  The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.", "recall_initiation_date": "20180919", "center_classification_date": "20181002", "termination_date": "20200626", "report_date": "20181010", "code_info": "Lot S91616", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0079-2019", "product_description": "Finafta Baby, Oral Gel (benzocaine 7.5%), 7.1 Grams (0.25 Oz.) tube, Distributed By: Efficient Laboratories, Inc., Miami, FL  33166.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090866"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5807", "0378-5813", "0378-5814", "0378-5815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["a5384d58-48c7-494a-a8a8-c296b316bd91"], "spl_set_id": ["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"], "package_ndc": ["0378-5807-93", "0378-5813-77", "0378-5814-77", "0378-5815-77"], "is_original_packager": [true], "upc": ["0303785815778", "0303785813774", "0303785807933", "0303785814771"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0327-2019", "product_description": "Valsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-5815-77.", "product_quantity": "129,754 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot Numbers:  3063783    3063784    3063785    3064092  3064093    3064094    3070349    3070350  3070351    3070352    3070353    3070354    3079030    3079031    3079032    3079033    3080011    3080224    3081498    3081500    3087126    3088476"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0195-2019", "product_description": "Trimix T 101 Alprostadil/Papverine/Phentolamine 5.9 mcg/17.65 mg/0.59 mcg per mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1336-05", "product_quantity": "20 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05312018:22 Discard by: 6/30/2018"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0054-2019", "product_description": "TopCare, Saline Nasal Gel with Soothing Aloe, 0.5 OZ (14 g) tube, Distributed By Topco Associates LLC, Elk Grove Village, IL 60007, UPC 0 36800 42146 2.", "product_quantity": "7,488 tubes", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0150-2019", "product_description": "Dexpanthenol Injection, 250 mg/mL Pharm D Solutions, Houston, Texas --- NDC 69699-1610-30", "product_quantity": "2000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 08292018:08 Discard by: 2/23/2019"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81457", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0257-2019", "product_description": "Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDC 0185-0122-01); and b) 1000-capsule bottles, (NDC 0185-0122-10); Rx Only, Distributed by Sandoz Inc. Princeton, NJ 08540", "product_quantity": "14366 bottles", "reason_for_recall": "Cross Contamination with Other Products", "recall_initiation_date": "20181102", "center_classification_date": "20181120", "termination_date": "20201002", "report_date": "20181121", "code_info": "Lots: a) JB4952, JA7322 Exp. 03/2020; b) JA7324, Exp.03/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0030-2019", "product_description": "CVS Health, Sterile Saline Nasal Mist (sodium chloride) Saline Nasal Moisturizer, 0.9%, packaged in a) Net Wt. 1.52 OZ (43 g) can UPC 0 50428 37079 7 Product #896831; b) Net Wt. 4.25 OZ (120 g) can UPC 0 50428 36124 5; c) Children's Net Wt. 2 OZ (57 g) can UPC 0 50428 58685 3 Product #282472,  Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895.", "product_quantity": "529,536 cans", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81457", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0262-2019", "product_description": "Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, 100-count bottoles, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141 Manufactured by: Sandoz Inc. Princeton, NJ 08540,NDC 16714-439-01", "product_quantity": "23053 bottles", "reason_for_recall": "Cross Contamination with Other Products", "recall_initiation_date": "20181102", "center_classification_date": "20181120", "termination_date": "20201002", "report_date": "20181121", "code_info": "Lot #: JA7319, JA 7320, JA7321, Exp.  03/2020", "more_code_info": ""}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090866"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5807", "0378-5813", "0378-5814", "0378-5815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["a5384d58-48c7-494a-a8a8-c296b316bd91"], "spl_set_id": ["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"], "package_ndc": ["0378-5807-93", "0378-5813-77", "0378-5814-77", "0378-5815-77"], "is_original_packager": [true], "upc": ["0303785815778", "0303785813774", "0303785807933", "0303785814771"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0325-2019", "product_description": "Valsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5813-77.", "product_quantity": "119,761 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot Numbers: 3065445, 3074880, 3074883, 3086688, 3086689, 3086710"}, {"country": "United States", "city": "Fort Worth", "address_1": "4201 Diplomacy Rd", "reason_for_recall": "Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.", "address_2": "", "product_quantity": "5363 tubes", "code_info": "Lot #: 131965, Exp 12/2018; 127426 Exp. 01/2019; 129045, 130424 Exp. 06/2019; 130432 Exp. 10/2019; 131870 Exp. 06/2019; 132648, Exp. 03/2020; 133732 Exp. 04/2020; 134400 Exp. 02/2020; 135345 Exp. 08/2020", "center_classification_date": "20181220", "distribution_pattern": "United States, Maldives, Canada, United Arab Emirates, and New Zealand", "state": "TX", "product_description": "Advanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 Oz/127.5 g tube.", "report_date": "20181226", "classification": "Class III", "openfda": {}, "recalling_firm": "CBI Laboratories, Inc.", "recall_number": "D-0341-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81775", "termination_date": "20200114", "more_code_info": "", "recall_initiation_date": "20181210", "postal_code": "76155-2633", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0196-2019", "product_description": "Trimix 30-1-30 Papavarin 30 mg/Phentolamine 1 mg/Alprostadil 30 mg/mL Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1319-10", "product_quantity": "50 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06192018:98 Discard by: 12/16/2018"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81311", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0095-2019", "product_description": "Meropenem for Injection, USA (I.V.), 1 gram/vial, 25 vials per carton, Sterile, Rx Only, Manufactured for: Hospira, Inc., Lake Forest, IL 60045, USA.  NDC carton: 0409-3506-01; NDC vial: 0409-3506-11", "product_quantity": "71,075 vials", "reason_for_recall": "Lack of assurance of sterility: loss of container integrity.", "recall_initiation_date": "20180920", "center_classification_date": "20181024", "termination_date": "20220917", "report_date": "20181031", "code_info": "Lot: 609G047, EXP 10/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0214-2019", "product_description": "Testosterone Cypionate/Proprinate 200 mg/10 mg/1 mL 30 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1745-30", "product_quantity": "580 vials and 30000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 02272018:63/A Discard by: 2/22/2019; 08162018:63/A Discard by: 4/30/2019; 10092017:30 Discard by: 10/1/2018; 02272018:63 Discard by: 2/22/2019; 08162018:63 Discard by: 4/30/2019"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0108-2019", "product_description": "Woman Power, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879 NDC 61096-0034-1 and Tester NDC 61096-1034-1", "product_quantity": "1,284 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Grand Island", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA088912"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807632", "1807636", "1807637", "1807638"], "spl_id": ["75c567e3-582b-4fff-9a72-f326f1d13c8f"], "spl_set_id": ["f62481fd-fcdb-4be6-ac13-29c590e925c3"], "package_ndc": ["63323-186-04", "63323-186-02", "63323-186-01", "63323-186-10", "63323-186-03", "63323-186-20"], "is_original_packager": [true], "upc": ["0363323186036"], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "81570", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3159 Staley Rd", "address_2": "N/A", "postal_code": "14072-2028", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Puerto RIco", "recall_number": "D-0298-2019", "product_description": "SODIUM CHLORIDE INJECTION, USP, 0.9%, 10 mL Single Dose Vial, packaged in a 25-unit tray, Rx Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173. NDC 63323-186-10 Product code 918610", "product_quantity": "23,745,300 10 mL vials", "reason_for_recall": "Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex.  The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex.  The above listed product codes and batches being recalled have stoppers containing natural rubber latex.", "recall_initiation_date": "20181115", "center_classification_date": "20181214", "termination_date": "20230501", "report_date": "20181212", "code_info": "Lot#         EXP date:  6013112 11/2018  6013113 11/2018  6013114 11/2018  6013180 11/2018  6013181 11/2018  6013182 11/2018  6013237 01/2019  6013238 01/2019  6013239 01/2019  6013468 02/2019  6013512 02/2019  6013513 02/2019  6013551 02/2019  6013552 02/2019  6013553 02/2019  6013607 02/2019  6013608 02/2019  6013610 02/2019  6013627 03/2019  6013678 03/2019  6013679 03/2019  6013822 03/2019  6013823 03/2019  6013824 03/2019  6013924 04/2019  6013925 04/2019  6013926 04/2019  6014003 05/2019  6014004 05/2019  6014005 05/2019  6014260 05/2019  6014301 05/2019  6014302 05/2019  6014303 06/2019  6014304 06/2019  6014305 06/2019  6014306 06/2019  6014307 06/2019  6014384 06/2019  6014404 06/2019  6014405 06/2019  6014453 06/2019  6014454 06/2019  6014455 06/2019  6014479 06/2019  6014557 07/2019  6014558 07/2019  6014606 07/2019  6014649 08/2019  6014650 08/2019  6014704 08/2019  6014766 08/2019  6014767 08/2019  6014768 08/2019  6014841 08/2019  6014842 08/2019  6014843 08/2019  6014861 08/2019  6014862 08/2019  6014863 08/2019  6015049 09/2019  6015050 09/2019  6015088 09/2019  6015118 10/2019  6015127 10/2019  6015128 10/2019  6015186 10/2019  6015187 10/2019  6015188 10/2019  6015233 10/2019  6015234 10/2019  6015235 10/2019  6015285 11/2019  6015286 11/2019  6015287 11/2019  6015408 11/2019  6015409 11/2019  6015410 11/2019  6015452 11/2019  6015453 11/2019  6015454 11/2019  6015572 11/2019  6015573 12/2019  6015574 12/2019  6015616 12/2019  6015617 12/2019  6015618 12/2019  6015922 01/2020  6015923 01/2020  6015924 01/2020  6016002 02/2020  6016003 02/2020  6016004 02/2020  6016077 02/2020  6016104 02/2020  6016208 02/2020  6016209 02/2020  6016210 02/2020  6016258 02/2020  6016259 02/2020  6016260 02/2020  6016261 02/2020  6016262 03/2020  6016263 03/2020  6016264 03/2020  6016323 03/2020  6016324 03/2020  6016325 03/2020  6016383 03/2020  6016384 03/2020  6016385 03/2020  6016386 03/2020  6016387 03/2020  6016388 03/2020  6016389 03/2020  6016584 04/2020  6016585 04/2020  6016621 04/2020  6016622 04/2020  6016623 04/2020  6016765 05/2020  6016766 05/2020  6016767 05/2020  6016768 05/2020  6016769 05/2020  6016875 06/2020  6016876 06/2020  6016877 06/2020  6016878 06/2020  6016879 06/2020  6017288 06/2020  6017289 06/2020  6017290 06/2020  6017291 06/2020  6017382 07/2020  6017425 07/2020  6017426 07/2020  6017427 07/2020  6017428 07/2020  6017429 07/2020  6017470 07/2020  6017471 07/2020  6017472 07/2020  6017473 07/2020  6017474 07/2020  6017675 08/2020  6017725 08/2020  6017726 08/2020  6013062 11/2018  6014162 05/2019  6014163 05/2019  6014164 05/2019  6014377 06/2019  6014378 06/2019  6014379 06/2019  6016005 02/2020  6016071 02/2020  6016072 02/2020  6016073 02/2020  6017383 07/2020  6017384 07/2020  6017422 07/2020  6017423 07/2020  6017424 07/2020    non US  6013112 11/2018  6013113 11/2018  6013114 11/2018  6013180 11/2018  6013181 11/2018  6013182 11/2018  6013237 01/2019  6013238 01/2019  6013239 01/2019  6013468 02/2019  6013512 02/2019  6013513 02/2019  6013551 02/2019  6013552 02/2019  6013553 02/2019  6013607 02/2019  6013608 02/2019  6013610 02/2019  6013627 03/2019  6013678 03/2019  6013679 03/2019  6013822 03/2019  6013823 03/2019  6013824 03/2019  6013924 04/2019  6013925 04/2019  6013926 04/2019  6014003 05/2019  6014004 05/2019  6014005 05/2019  6014260 05/2019  6014301 05/2019  6014302 05/2019  6014303 06/2019  6014304 06/2019  6014305 06/2019  6014306 06/2019  6014307 06/2019  6014384 06/2019  6014404 06/2019  6014405 06/2019  6014453 06/2019  6014454 06/2019  6014455 06/2019  6014479 06/2019  6014557 07/2019  6014558 07/2019  6014606 07/2019  6014649 08/2019  6014650 08/2019  6014704 08/2019  6014766 08/2019  6014767 08/2019  6014768 08/2019  6014841 08/2019  6014842 08/2019  6014843 08/2019  6014861 08/2019  6014862 08/2019  6014863 08/2019  6015049 09/2019  6015050 09/2019  6015088 09/2019  6016209 02/2020  6016210 02/2020  6016258 02/2020  6016259 02/2020  6016260 02/2020  6016261 02/2020  6016262 03/2020  6016263 03/2020  6016264 03/2020  6016323 03/2020  6016324 03/2020  6016325 03/2020  6016383 03/2020  6016384 03/2020  6016385 03/2020  6016386 03/2020  6016387 03/2020  6016388 03/2020  6016389 03/2020  6016584 04/2020  6016585 04/2020  6016621 04/2020  6016622 04/2020  6016623 04/2020  6016765 05/2020  6016766 05/2020  6016767 05/2020  6016768 05/2020  6016769 05/2020  6016875 06/2020  6016876 06/2020  6016877 06/2020  6016878 06/2020  6016879 06/2020  6017288 06/2020  6017289 06/2020  6017290 06/2020  6017291 06/2020  6017382 07/2020  6017425 07/2020  6017426 07/2020  6017427 07/2020  6017428 07/2020  6017429 07/2020  6017470 07/2020  6017471 07/2020  6017472 07/2020  6017473 07/2020  6017474 07/2020  6017675 08/2020  6017726 08/2020"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077073"], "brand_name": ["AMLODIPINE BESYLATE"], "generic_name": ["AMLODIPINE BESYLATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-126", "69097-127", "69097-128"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE"], "rxcui": ["197361", "308135", "308136"], "spl_id": ["acf4c672-f280-41fe-a57c-67df24582038"], "spl_set_id": ["5409b296-3bed-47cd-abba-9fe6f6833af6"], "package_ndc": ["69097-126-05", "69097-126-15", "69097-127-05", "69097-127-15", "69097-128-05", "69097-128-15", "3690971281"], "is_original_packager": [true], "upc": ["0369097128050", "0369097126056", "0369097127053", "369097128159"], "unii": ["864V2Q084H"]}, "product_type": "Drugs", "event_id": "81099", "recalling_firm": "InvaGen Pharmaceuticals, Inc.", "address_1": "7 Oser Ave", "address_2": "", "postal_code": "11788-3811", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide with the United States", "recall_number": "D-0012-2019", "product_description": "Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323  UPC 369097128159, NDC 69097-128-15", "product_quantity": "2880 bottles", "reason_for_recall": "Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month  long term stability condition.", "recall_initiation_date": "20181003", "center_classification_date": "20181011", "termination_date": "20210713", "report_date": "20181017", "code_info": "Lot #: GG80218, Exp. 12/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81638", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two medical facilities in Pennsylvania.", "recall_number": "D-0284-2019", "product_description": "Nitrofurantoin Monohydrate/Macrocrystals capsules,100 mg, packaged in HDPE 60 cc bottles, Rx only, MFG: Sandoz Inc., Princeton, NJ, Repackaged by: RemedyRepack, Indiana, PA, Original NDC 00185-0122-01Repackaged NDC 70518-1087-00, 14 capsules in HDPE 60 cc bottles in cardboard trays & HDPE 60 cc bottles in plastic bags, Repackaged NDC 70518-1087-01, 10 capsules in HDPE 60 cc bottles in cardboard trays.", "product_quantity": "3,148 capsules", "reason_for_recall": "Cross contamination with other products: Product is being recalled due to the potential presence of unrelated ingredients (Benazepril, Haloperidol and Perphenazine).", "recall_initiation_date": "20181107", "center_classification_date": "20181127", "termination_date": "20190401", "report_date": "20181205", "code_info": "Lot #: B0484872-081718, B0481339-081018, Exp 08/2019; B0506246-092718, Exp 09/2019; B0509938-100418, Exp 10/2019"}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0318-2019", "product_description": "Amlodipine and Valsartan Tablets, USP, 10 mg/320 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-1724-93.", "product_quantity": "48,302 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3061986, exp. date 11/2018   Lot # 3079709, exp. date 1/2020   Lot # 3077618, exp. date 11/2019   Lot # 3079708, exp. date 1/2020"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206906"], "brand_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "generic_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-854", "65862-855", "65862-856", "65862-857"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "OLMESARTAN MEDOXOMIL"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_id": ["4879a01c-0ba7-4d27-9847-f22e8546fa8f"], "spl_set_id": ["b13a8b46-104e-4b75-8f4a-928d2204eff5"], "package_ndc": ["65862-854-30", "65862-855-30", "65862-856-30", "65862-857-30"], "is_original_packager": [true], "upc": ["0365862855305", "0365862856302", "0365862854308", "0365862857309"], "unii": ["6M97XTV3HD", "864V2Q084H"]}, "product_type": "Drugs", "event_id": "81703", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0289-2019", "product_description": "Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 0852 Made in India, NDC 65862-855-30", "product_quantity": "4464 bottles", "reason_for_recall": "Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).", "recall_initiation_date": "20181130", "center_classification_date": "20181206", "termination_date": "20220201", "report_date": "20181212", "code_info": "Lot#: OWSA18002-A, Exp 7/2020"}, {"country": "United States", "city": "Hurst", "address_1": "122 Grapevine Hwy", "reason_for_recall": "Labeling Not Elsewhere Classified: Misbranding.", "address_2": "", "product_quantity": "8240 capsules", "code_info": "Lots: 04052018@16 Exp. 9/11/2018; 04242018@2 Exp. 10/21/2018; 05072018@8 Exp. 10/21/2018; 05302018@3 Exp. 10/22/2018; 06192018@9 Exp. 10/22/2018; 06192018@10 Exp. 12/15/2018; 06202018@12 Exp. 12/15/2018; 07022018@15 Exp. 12/15/2018; 07242018@2 Exp. 1/13/2018; 08312018@3 Exp. 2/6/2018", "center_classification_date": "20181114", "distribution_pattern": "Distributed in California", "state": "TX", "product_description": "Progesterone SR 200 mg Capsules, packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd's Prescription Shop 122 Grapevine Hwy. Hurst, TX 76054 817-282-9376. NDC 99999-0018-74", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "Right Value Drug Stores, Inc.", "recall_number": "D-0241-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81198", "termination_date": "20201013", "more_code_info": "", "recall_initiation_date": "20180925", "postal_code": "76054-2406", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0080-2019", "product_description": "Family Dollar Saline Nasal Spray 4.25 oz. can, 24 pk, SKU 0900562.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0156-2019", "product_description": "HCG Lyophilized 5000 IU Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1707-10", "product_quantity": "2219 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04252018:33 Discard by: 10/21/2018; 05082018:39 Discard by: 11/4/2018; 06262018:00 Discard by: 12/23/2018; 07192018:13 Discard by: 1/15/2019; 08012018:46 Discard by: 1/28/2019; 08212018:69 Discard by: 11/30/2018"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202501"], "brand_name": ["CIDOFOVIR DIHYDRATE"], "generic_name": ["CIDOFOVIR DIHYDRATE"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-216"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CIDOFOVIR"], "rxcui": ["199388"], "spl_id": ["963405a6-8cd9-4d70-9de9-2afc6eab1488"], "spl_set_id": ["44966a7e-d777-40fb-956f-d0f31f737848"], "package_ndc": ["23155-216-31", "3231552163"], "is_original_packager": [true], "upc": ["0323155216318"], "unii": ["JIL713Q00N"]}, "product_type": "Drugs", "event_id": "81276", "recalling_firm": "Heritage Pharmaceuticals, Inc.", "address_1": "1 Tower Center Blvd Ste 1700", "address_2": "N/A", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0094-2019", "product_description": "Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd Hinjawadi, Pune, India, Mfg for: Heritage Pharmaceuticals Inc. UPC 323155216388, NDC 23155-216-31", "product_quantity": "2,789 Units", "reason_for_recall": "Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle", "recall_initiation_date": "20181015", "center_classification_date": "20181024", "termination_date": "20230329", "report_date": "20181031", "code_info": "Lot #: VCIA083, Exp. JUN2020"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0070-2019", "product_description": "Cicatricure, Scar Cream + Sunscreen SPF 30 (avobenzone 3%, octocrylene 10%, oxybenzone 6%), 0.7 oz. (19.8 g) tube, Distributed by: Genomma Lab USA Inc., Houston, TX 77027, UPC 6 50067 00018 7.", "product_quantity": "7,944 tubes", "reason_for_recall": "Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot: 163241K, Exp. October 2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0139-2019", "product_description": "Beta-complex B-1, B-6, B-3, B-12, B-5 100, 2.54 Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1611-30", "product_quantity": "6000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06182018:55 Discard by: 12/25/2018"}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0311-2019", "product_description": "Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-1721-93.", "product_quantity": "23,478 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3066051, exp. date 3/2019"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0189-2019", "product_description": "Tilarginine Acetate 50 mg/mL, 10 mL, Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1461-10", "product_quantity": "3523 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06212018:28 Discard by: 12/11/2019; 06152018:24 Discard by: 12/12/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0174-2019", "product_description": "Prostaglandin E1 40 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1347-05", "product_quantity": "154 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04262018:95 Discard by: 10/22/2018; 03292018:59 Discard by: 9/24/2018; 05312018:66 Discard by: 11/27/2018; 06122018:07 Discard by: 12/9/2018"}, {"status": "Terminated", "city": "Madison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81535", "recalling_firm": "ALLERGAN", "address_1": "1 Giralda Farms", "address_2": "N/A", "postal_code": "07940-1027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0282-2019", "product_description": "INFed (Iron Dextran Injection USP) 100 mg elemental iron/2 mL (50 mg/mL), Rx only, packaged in 2 mL Sterile Single Dose Vial, Mfd by Patheon Italia S.p.A. Ferentino, Italy  NDC 52544-931-07", "product_quantity": "111,132 cartons/10 vials per carton", "reason_for_recall": "Failed Stability Specification: out of specification for iron content.", "recall_initiation_date": "20181108", "center_classification_date": "20181123", "termination_date": "20200406", "report_date": "20181205", "code_info": "Lot Numbers:  16W06A, 16W07A, 16W08A, exp. date 02/2019; 16W09A, 16W10A, exp. date 03/2019; 16W11A, 16W14A, exp. date 04/2019; 16W21A, exp. date 09/2019; 16W23A, exp. date 11/2019; 17W10A, exp. date 04/2020; 17W12A, exp. date 05/2020; 17W16A, 17W18A, exp. date 06/2020; 17W22A, exp. date 08/2020"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201546"], "brand_name": ["CHILDRENS ALLERGY"], "generic_name": ["CETIRIZINE HYDROCHLORIDE"], "manufacturer_name": ["Publix Super Markets Inc"], "product_ndc": ["56062-106"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CETIRIZINE HYDROCHLORIDE"], "rxcui": ["1014673"], "spl_id": ["29a2f347-2061-7d9a-e063-6294a90a98e9"], "spl_set_id": ["9a8b5af0-72bb-48d5-bb5e-0dc6808bf466"], "package_ndc": ["56062-106-08"], "is_original_packager": [true], "upc": ["0041415435735", "041415435735"], "unii": ["64O047KTOA"]}, "product_type": "Drugs", "event_id": "81483", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0277-2019", "product_description": "children's allergy (cetirizine hydrochloride) Oral Solution, 1 mg/mL, ANTIHISTAMINE, Dye-Free, Sugar-Free, 4 FL OZ (120 mL) bottle, Distributed by Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811, NDC 56062-106-08, UPC 0 41415 43573 5.", "product_quantity": "8328 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.", "recall_initiation_date": "20181019", "center_classification_date": "20181120", "termination_date": "20201103", "report_date": "20181121", "code_info": "Lot # 313345, Exp 12/18", "more_code_info": ""}, {"country": "United States", "city": "Monmouth Junction", "address_1": "2033 US Highway 130", "reason_for_recall": "Superpotent Drug: recalled lots may have higher concentration of ibuprofen.", "address_2": "", "product_quantity": "19,488 bottles", "code_info": "Lot #: 00717024A, Exp 08/19", "center_classification_date": "20181217", "distribution_pattern": "One distributor in PA who further distributed Nationwide in the USA.", "state": "NJ", "product_description": "Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye-Free Non-Staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Family Dollar Services, Inc., 10301 Monroe Road, Matthews, NC 28105, NDC 55319-250-23, UPC 0 32251 03374 2.", "report_date": "20181226", "classification": "Class II", "openfda": {}, "recalling_firm": "Tris Pharma Inc.", "recall_number": "D-0336-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81354", "termination_date": "20210401", "more_code_info": "", "recall_initiation_date": "20181126", "postal_code": "08852-3003", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0074-2019", "product_description": "Sinus Relief (oxymetazoline HCl) Nasal decongestant, 0.05%, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 43236 5.", "product_quantity": "16 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Pseudomonas aeruginosa.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot: 173089J Exp. 09/19"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0190-2019", "product_description": "Tri-Mix XL 150 mg/10 mg/100 mcg a) Injectable NDC 69699-1353-10; b) (LYO) Powder NDC 69699-1353-10, Pharm D Solutions, Houston, Texas", "product_quantity": "553 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: a) 04132018:97 Discard by: 10/10/2018; 04032018:25 Discard by: 9/30/2018; b) 04162018:29 Discard by: 10/11/2018; 03282018:80 Discard by: 9/24/2018; 06122018:06 Discard by: 12/9/2018; 08132018:55 Discard by: 2/9/2019"}, {"country": "United States", "city": "Houston", "address_1": "1304 S Loop W", "reason_for_recall": "Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.", "address_2": "", "product_quantity": "85 vials", "code_info": "Lot: 10292018:21 Exp. 3/31/2019", "center_classification_date": "20181220", "distribution_pattern": "WA", "state": "TX", "product_description": "Human Chorionic Gonadotropin 3000 IU, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054 1-844-263-6843 --- NDC: 69699-1738-10", "report_date": "20181226", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharm D Solutions, LLC", "recall_number": "D-0343-2019", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "81629", "termination_date": "20201013", "more_code_info": "", "recall_initiation_date": "20181119", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0321-2019", "product_description": "Amlodipine and Valsartan Tablets, USP 10/160 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-1722-93.", "product_quantity": "76,516 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot numbers: 3064085, 3066063,3069638,3069639"}, {"country": "United States", "city": "Indiana", "address_1": "625 Kolter Dr Ste 4", "reason_for_recall": "Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot #: A0A0253, Exp. 02/2019; Lot #: B0369427-112717, Exp. 08/2019", "center_classification_date": "20181114", "distribution_pattern": "1 vial was distributed to a medical facility in Mayville, NY.", "state": "PA", "product_description": "Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "RemedyRepack Inc.", "recall_number": "D-0245-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81554", "termination_date": "20190205", "more_code_info": "", "recall_initiation_date": "20181026", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA200490"], "brand_name": ["LEVONORGESTREL AND ETHINYL ESTRADIOL"], "generic_name": ["LEVONORGESTREL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-7281"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["238019", "748797", "751901"], "spl_id": ["bb7e6361-692e-4bf9-9bfa-da7da696cc5a"], "spl_set_id": ["af93fc89-c813-4a8c-9909-44729ab25a64"], "package_ndc": ["0378-7281-85", "0378-7281-53"], "is_original_packager": [true], "upc": ["0303787281533"]}, "product_type": "Drugs", "event_id": "81221", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0025-2019", "product_description": "Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing 91 tablets each, Made in India, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7281-53.", "product_quantity": "5,790 cartons (526,890 tablets)", "reason_for_recall": "Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.", "recall_initiation_date": "20180827", "center_classification_date": "20181014", "termination_date": "20190726", "report_date": "20181024", "code_info": "Lot # 8508F004A; Exp. 02/20"}, {"status": "Terminated", "city": "LAKE FOREST", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81199", "recalling_firm": "ICU Medical Inc", "address_1": "600 N FIELD DRIVE", "address_2": "", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0216-2019", "product_description": "0.9% Sodium Chloride Injection, USP Rx Only a) 250 mL NDC 0409-7983-02; b) 150 mL NDC 0409-7983-61; c) 50 mL NDC 0409-7984-36; d) 100 mL NDC 0409-7984-37, Hospira, Inc. Lake Forest, IL 60045", "product_quantity": "2,580,448 bags", "reason_for_recall": "Lack of Assurance of Sterility; bags have the potential to leak", "recall_initiation_date": "20181008", "center_classification_date": "20181102", "termination_date": "20210308", "report_date": "20181114", "code_info": "Lots: a) 84-011-JT Exp. December 01, 2019 and 85-014-JT Exp. January 01, 2020; b) 84-015-JT Exp. December 01, 2019; c) 84-016-JT Exp. June 01, 2019; d) 84-005-JT Exp. December 01, 2019 and 84-014-JT Exp. December 01, 2019", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81316", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. nationwide", "recall_number": "D-0130-2019", "product_description": "Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701.  NDC  7073197450", "product_quantity": "395 vials", "reason_for_recall": "Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.", "recall_initiation_date": "20180925", "center_classification_date": "20181101", "termination_date": "20221018", "report_date": "20181031", "code_info": "Lot# 04042018:58, Exp 10/17/18"}, {"status": "Terminated", "city": "Gainesville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80838", "recalling_firm": "Westlab Pharmacy, Inc. dba Westlab Pharmacy", "address_1": "4410 W Newberry Rd Ste A5", "address_2": "N/A", "postal_code": "32607-2290", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0091-2019", "product_description": "Cyclosporine 1% Human Eye Drops, Westlab Pharmacy, Inc., Gainesville, FL 32607 NDC 10002-2776-92", "product_quantity": "7 droptainers", "reason_for_recall": "Lack of Process Controls", "recall_initiation_date": "20180810", "center_classification_date": "20181024", "termination_date": "20200507", "report_date": "20181031", "code_info": "Lot: 07262018@7 Exp. 08/25/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0151-2019", "product_description": "Epi-Shugarcaine Kit Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1409-60", "product_quantity": "70 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "08272018:79 Discard by: 10/1/2018"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0072-2019", "product_description": "Mushatt's No. 9, PsoriWash Medicated Wash, Salicylic Acid 1.8%, 8 oz. (226 g) tube, Distributed by Mushatts, LLC, P.O. Box 372476, Satellite Beach, FL 32937, UPC 8 58245 00203 3.", "product_quantity": "1,440 tubes", "reason_for_recall": "Microbial Contamination of Non-Sterile Products and Subpotent Drug: failure for microbiological growth exceeding specification and low out of specification assay results for salicylic acid.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot: 161794F"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0158-2019", "product_description": "HCG Reconstitued 6000 IU Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1739-06", "product_quantity": "10 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 09062018:83 Discard by: 10/6/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0211-2019", "product_description": "Water Sterile for Injection 250 mL IV Pharm D Solutions, Houston, Texas --- NDC 69699-1407-25", "product_quantity": "12 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05222018:12 Discard by: 10/21/2018"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C236 BUD: 11/13/2018", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 12.5mg pellet, 1 count (NDC 69761-012-01), 6 count (NDC 69761-012-06), 12 count (NDC 69761-012-12), and 30 count (NDC 69761-012-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0226-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0050-2019", "product_description": "QC Quality Choice, Saline Nasal Relief, Moisturizing Nasal Spray, Sodium Chloride 0.65%, packaged as a) 1.5 FL OZ (45 mL) bottle UPC 6 35515 98845 3; b) 3 FL OZ (89 mL) bottle UPC 6 35515 95042 9, Distributed by C.D.M.A., Inc., 43157 W. Nine Mile, Novi, MI 48376-0995.", "product_quantity": "172,800 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Aventura", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81436", "recalling_firm": "Zero Xtreme USA", "address_1": "20533 Biscayne Blvd # 825", "address_2": "", "postal_code": "33180-1529", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the USA.", "recall_number": "D-0246-2019", "product_description": "Zero Xtreme Dietary Supplement 30-count capsules.  By:Zero Xtreme Registro Sanitario No SD2014-0002208 LLC-USA", "product_quantity": "16 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Undeclared Sibutramine", "recall_initiation_date": "20181015", "center_classification_date": "20181115", "termination_date": "20220118", "report_date": "20181121", "code_info": "Lot: 1220062085 Exp. 03/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0040-2019", "product_description": "Harmon Face Values, Saline Nasal Spray (sodium chloride), 0.65%, packaged as a) 1.5 FL OZ (44 mL) bottle UPC 7 27510 00501 0; b) 3 FL OZ (88 mL) bottle UPC 7 27510 00502 7, Distributed by Harmon Stores, Inc., Union, NJ 07083 USA.", "product_quantity": "39,924 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0041-2019", "product_description": "meijer, Saline Nasal Spray, Nasal Moisturizing Spray, packaged as a) 1.5 FL OZ (44 mL) UPC 7 08820 74428 8; b) 3FL OZ (88 mL) UPC 7 08820 74430 1, Dist. By Meijer Distribution, Inc., Grand Rapids, MI 49544 .", "product_quantity": "182,568 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}]